Koga, Tomoyuki http://orcid.org/0000-0002-8330-117X
Chaim, Isaac A. http://orcid.org/0000-0003-1787-046X
Benitez, Jorge A. http://orcid.org/0000-0003-3185-9056
Markmiller, Sebastian
Parisian, Alison D.
Hevner, Robert F.
Turner, Kristen M.
Hessenauer, Florian M.
D’Antonio, Matteo http://orcid.org/0000-0001-5844-6433
Nguyen, Nam-phuong D.
Saberi, Shahram
Ma, Jianhui
Miki, Shunichiro
Boyer, Antonia D.
Ravits, John
Frazer, Kelly A. http://orcid.org/0000-0002-6060-8902
Bafna, Vineet
Chen, Clark C.
Mischel, Paul S. http://orcid.org/0000-0002-4560-2211
Yeo, Gene W.
Furnari, Frank B. http://orcid.org/0000-0003-1909-4361
Article History
Received: 24 October 2019
Accepted: 20 December 2019
First Online: 28 January 2020
Change Date: 20 April 2020
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Competing interests
: The authors declare the following competing interests: P.S.M. is a co-founder of Boundless Bio, Inc. (BB). He has equity interest in the company and serves as the chair of the Scientific Advisory Board. V.B. is a co-founder, serves on the scientific advisory board and has an equity interest in BB and Digital Proteomics, LLC (DP), and receives income from DP. The terms of this arrangement have been reviewed and approved by the University of California, San Diego in accordance with its conflict of interest policies. BB and DP were not involved in the research presented here. K.M.T became an employer of Boundless Bio after submission of this manuscript. G.W.Y. is a co-founder, member of the Board of Directors, equity holder, and paid consultant for Eclipse BioInnovations. The terms of these arrangements have been reviewed and approved by the University of California, San Diego in accordance with its conflict of interest policies. The remaining authors declare no competing interests.